Panoskaltsis-Mortari A - Search Results

1

Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes.

Burwitz BJ, Wu HL, Abdulhaqq S, Shriver-Munsch C, Swanson T, Legasse AW, Hammond KB, Junell SL, Reed JS, Bimber BN, Greene JM, Webb GM, Northrup M, Laub W, Kievit P, MacAllister R, Axthelm MK, Ducore R, Lewis A, Colgin LMA, Hobbs T, Martin LD, Ferguson B, Thomas CR Jr, Panoskaltsis-Mortari A, Meyers G, Stanton JJ, Maziarz RT, Sacha JB. Burwitz BJ, et al. Nat Commun. 2017 Nov 10;8(1):1418. doi: 10.1038/s41467-017-01631-z. Nat Commun. 2017. PMID: 29127275 Free PMC article.

2

Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.

Holtan SG, Verneris MR, Schultz KR, Newell LF, Meyers G, He F, DeFor TE, Vercellotti GM, Slungaard A, MacMillan ML, Cooley SA, Blazar BR, Panoskaltsis-Mortari A, Weisdorf DJ. Holtan SG, et al. Biol Blood Marrow Transplant. 2015 Jun;21(6):1029-36. doi: 10.1016/j.bbmt.2015.02.018. Epub 2015 Mar 7. Biol Blood Marrow Transplant. 2015. PMID: 25759146 Free PMC article. Clinical Trial.

3

Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation.

Newell LF, DeFor TE, Cutler C, Verneris MR, Blazar BR, Miller JS, Antin JH, Howard A, Wu J, MacMillan ML, Panoskaltsis-Mortari A, Weisdorf DJ, Holtan SG. Newell LF, et al. Biol Blood Marrow Transplant. 2020 Mar;26(3):606-611. doi: 10.1016/j.bbmt.2019.11.006. Epub 2019 Nov 10. Biol Blood Marrow Transplant. 2020. PMID: 31715306 Free PMC article.

4

A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice.

Saha A, Hyzy S, Lamothe T, Hammond K, Clark N, Lanieri L, Bhattarai P, Palchaudhuri R, Gillard GO, Proctor J, Riddle MJ, Panoskaltsis-Mortari A, MacMillan ML, Wagner JE, Kiem HP, Olson LM, Blazar BR. Saha A, et al. Blood. 2022 Mar 17;139(11):1743-1759. doi: 10.1182/blood.2021012366. Blood. 2022. PMID: 34986233 Free PMC article.

5

Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.

Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Gray GS, Vallera DA. Blazar BR, et al. Blood. 1995 May 1;85(9):2607-18. Blood. 1995. PMID: 7537122 Free article.

6

Interleukin-1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice.

Vallera DA, Taylor PA, Vannice JL, Panoskaltsis-Mortari A, Blazar BR. Vallera DA, et al. Transplantation. 1995 Dec 15;60(11):1371-4. Transplantation. 1995. PMID: 8525541

7

Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens.

Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Barrett TA, Bluestone JA, Vallera DA. Blazar BR, et al. Blood. 1996 Jan 15;87(2):827-37. Blood. 1996. PMID: 8555509 Free article.

8

In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A.

Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Sehgal S, Vallera DA. Blazar BR, et al. Blood. 1996 May 1;87(9):4001-9. Blood. 1996. PMID: 8611733 Free article.

9

Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.

Blazar BR, Sharpe AH, Taylor PA, Panoskaltsis-Mortari A, Gray GS, Korngold R, Vallera DA. Blazar BR, et al. J Immunol. 1996 Oct 15;157(8):3250-9. J Immunol. 1996. PMID: 8871619

10

Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.

Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Buhlman J, Xu J, Flavell RA, Korngold R, Noelle R, Vallera DA. Blazar BR, et al. J Immunol. 1997 Jan 1;158(1):29-39. J Immunol. 1997. PMID: 8977172

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters